Showing results (141-150 of 361) with videos related to
Sort By:
Pageof 37
Cancer Genomics & Proteomics|September 30, 2008
Molecular mechanisms of action of imatinib mesylate in human ovarian cancer: a proteomic analysisBhavinkumar B Patel, Yin A He, Xin-Ming Li, et al.Cancer Biology & Therapy|May 28, 2011
Novel surface targets and serum biomarkers from the ovarian cancer vasculatureDimitra Sasaroli, Phyllis A Gimotty, Harsh B Pathak, et al.Biomarker Insights|November 7, 2022
MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 TranslocationJennifer Crow, Glenson Samuel, Emily Farrow, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group StudyRussell J Schilder, Michael W Sill, Xiaowei Chen, et al.Cancer|December 12, 2003
Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomiesIsabelle H Roland, Wan-Lin Yang, Dong-Hua Yang, et al.Plos One|April 25, 2009
Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA librariesStacia K Wyman, Rachael K Parkin, Patrick S Mitchell, et al.Cancer|March 3, 2007
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancerEdwin M Posadas, Meghan S Liel, Virginia Kwitkowski, et al.Journal of Cancer Research and Clinical Oncology|March 26, 2025
Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluationsSoumya M Turaga, Stacey L Hembruff, Masha G Savelieff, et al.Oncogene|July 26, 2002
Elevated JNK activation contributes to the pathogenesis of human brain tumorsMarc A Antonyak, Lawrence C Kenyon, Andrew K Godwin, et al.Cancer Heterogeneity and Plasticity|May 11, 2026
Keratin 5 marks cancer-propagating cells sustained by an osteopontin-producing niche in high-grade serous ovarian carcinomaMallikarjun Bidarimath, Coulter Q Ralston, Nandini Bidarimath, et al.Pageof 37